Managed Healthcare Executive July 14, 2021
Briana Contreras

International Generic and Biosimilar Medicines Association recently released the report, “A Vision for the Global Generic and Biosimilar Medicines Industry,” covering the current global Generic and Biosimilar medicine industry, and released a vision of what the market will be in 2030 and how to achieve it.

The International Generic and Biosimilar Medicines Association (IGBA) recently released a report which takes a look at the current global Generic and Biosimilar medicine industry, and released a vision of what the market will be in 2030.

The report, “A Vision for the Global Generic and Biosimilar Medicines Industry,” covers the contribution of the pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry, as well as its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
FTC wants more information on Novo's $16.5B deal to boost Wegovy production
FDA flags 10 observations in another Form 483 for a Zydus plant
Gates, Novo Nordisk And Wellcome Commit $300 Million To Climate Change, Infectious Diseases And Nutrition
Senate tackles drug shortages with new legislation
Opinion: The world is relying on the United States to get value-based drug pricing right

Share This Article